Results 141 to 150 of about 10,320 (199)

Baseline Characteristics of Patients in the CHEK1-low and CHEK1-high Groups.

Chen Chen (6544), Dan Gao (410390), Huan Yue (3701338), Huijing Wang (1643056), Rui Qu (1556371), Xiaochi Hu (17406287), Libo Luo (3602438)   +6 more
openalex   +1 more source

BRAF; checkpoint kinase 1 (Chk1; CHEK1); Chk2 (CHEK2); ataxia telangiectasia mutated (ATM); VEGF [PDF]

Science-Business eXchange, 2014
openaire   +1 more source

Mitochondrial inflexibility ignites tumor immunogenicity in postoperative glioblastoma. [PDF]

Nat Commun
Cheng L, Fang Z, Wang J, Xi K, Zhang Y, Feng F, Yu L, Santiago M, Wang J, Wu Z, Wang KN, Daubon T, Ni S, Zhang Y, Zhang Y.   +14 more
europepmc   +1 more source

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHEK1.

Shahan Mamoor
openalex   +1 more source

Development and validation of a novel signature to predict the survival and affect the immune microenvironment of esophageal squamous cell carcinoma: epigenetic-related genes. [PDF]

Front Immunol
Su Y, Zhang M, Zhang Q, Wen P, Xu K, Xie J, Wan X, Liu L, Xu P, Yang Z, Yang M.   +10 more
europepmc   +1 more source

Neural Latent Filtering for Gene Discovery in Breast Cancer Subtypes. [PDF]

Biotechnol Rep (Amst)
Menegatti D, Fiscon G, Giuseppi A, Paci P, Pietrabissa A.   +4 more
europepmc   +1 more source

Checkpoint kinase 1 in colorectal cancer: Upregulation of expression and promotion of cell proliferation. [PDF]

World J Clin Oncol
Pang YY, Chen ZY, Zeng DT, Li DM, Li Q, Huang WY, Li B, Luo JY, Chi BT, Huang Q, Feng ZB, He RQ.   +11 more
europepmc   +1 more source

RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells

Clinical Cancer Research, 2018
Xiaosong Yang, You Pan, Zhaojun Qiu, Zhanwen Du, Yao Zhang, Pengyan Fa, Shashank Gorityala, Shanhuai Ma, Shunqiang Li, Ceshi Chen, Hongbing Wang, Yan Xu, Chunhong Yan, Keri Ruth, Zhefu Ma, Junran Zhang   +15 more
semanticscholar   +1 more source

Case Report: Ivonescimab in EGFR-mutant lung cancer with baseline malignant pleural effusion and acquired complex resistance. [PDF]

Front Immunol
Mo Z, Jiang H, Zhou L, Ren Q, Shen G, Li L, Jian X, Yang H, Bai Y, Meng M, He S.   +10 more
europepmc   +1 more source

RBM17 Promotes the Chemoresistance of Oral Squamous Cancer Cells Through Checkpoint Kinase 1. [PDF]

Int J Mol Sci
Nakahara M, Arai R, Tokuoka I, Fukumura K, Mayeda A, Yashiro M, Nakahara H.   +6 more
europepmc   +1 more source